Originally published in Pharma's Almanac
Chris Economos, Chief Commercial Officer of PhysIQ, explains how the company utilizes artificial intelligence to analyze biosensor data, and specifically highlights how the technology has the potential to impact the industry, including how drugs are developed and patients are cared for.